What is Frontage Laboratories?
Frontage Laboratories, Inc. operates as a Contract Research Organization (CRO) providing integrated, science-driven product development services. Their comprehensive offerings span drug discovery and development, including drug metabolism and pharmacokinetics, analytical testing, formulation development, preclinical and clinical trial material manufacturing, bioanalysis, preclinical safety and toxicology assessment, and early-phase clinical studies. The company has a proven track record of assisting numerous biotechnology and leading pharmaceutical firms in advancing molecules through development and facilitating regulatory submissions across the United States, China, and other global markets.
How much funding has Frontage Laboratories raised?
Frontage Laboratories has raised a total of $10M across 1 funding round:
Angel/Seed
$10M
Angel/Seed (2008): $10M with participation from Baird Capital Partners Asia
Key Investors in Frontage Laboratories
Baird Capital Partners Asia
Baird Capital is a private equity and venture capital firm that invests in founder-led B2B tech and services companies globally. They manage two distinct investment strategies: Global Private Equity and Venture Capital, focusing on sectors where they possess deep institutional knowledge. The firm emphasizes a partnership approach with management teams, providing operational support and expertise to foster growth. Baird Capital is recognized for its strong culture and commitment to collaboration, making it a preferred partner for entrepreneurs and businesses seeking to scale.
What's next for Frontage Laboratories?
The recent major strategic investment, contextualized within Frontage Laboratories' history of enterprise-level funding, suggests a phase of significant scaling and expansion. This capital infusion is likely to fuel further enhancement of their integrated service offerings, potentially including the expansion of their preclinical and clinical capabilities, and the broadening of their geographical reach. The company is well-positioned to capitalize on the growing demand for outsourced drug development services, aiming to accelerate the path to market for novel therapeutics.
See full Frontage Laboratories company page
